Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

PCC0208009

Copy Product Info
🥰Excellent
Catalog No. T4142Cas No. 1668565-74-9
Alias IDO-IN-2, IDO inhibitor 1, DO-IN-2

PCC0208009 (IDO-IN-2) is an IDO inhibitor.

PCC0208009

PCC0208009

Copy Product Info
🥰Excellent
Purity: 99.89%
Catalog No. T4142Alias IDO-IN-2, IDO inhibitor 1, DO-IN-2Cas No. 1668565-74-9
PCC0208009 (IDO-IN-2) is an IDO inhibitor.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$39In StockIn Stock
2 mg$54In StockIn Stock
5 mg$89In StockIn Stock
10 mg$153In StockIn Stock
25 mg$286In StockIn Stock
50 mg$488In StockIn Stock
100 mg$673In StockIn Stock
1 mL x 10 mM (in DMSO)$98In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.89%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

PCC0208009 AI Summary
PCC0208009 inhibits IDO1 in IFN-gamma stimulated human HeLa cells by reducing kynurenine production, with an IC50 value of 4.0 nM. This compound also exhibits strong IDO1 inhibition in human HeLa cells with an IC50 of 7.0 nM and poor inhibition of TDO in HEK cells with an IC50 greater than 7500.0 nM. It shows moderate metabolic stability in various liver microsomes and demonstrates a transactivation of PXR with an EC50 of 1400.0 nM and an Emax of 110.0% relative to the control. Additionally, PCC0208009 inhibits multiple human CYP enzymes, including CYP2C9, CYP1A2, CYP2C19, CYP2D6, CYP3A4, CYP2C8, and CYP2B6, with varying IC50 values and displays species-dependent stability in liver microsomes..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
PCC0208009 (IDO-IN-2) is an IDO inhibitor.
Targets&IC50
IDO:3 nM
SynonymsIDO-IN-2, IDO inhibitor 1, DO-IN-2
Chemical Properties
Molecular Weight497.63
FormulaC29H35N7O
Cas No.1668565-74-9
SmilesCC(C)CN(CC(C)C)c1ccc(cc1NC(=O)Nc1ccc(C)cc1)-c1ccccc1-c1nn[nH]n1
Relative Density.1.206 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 60 mg/mL (120.57 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+90% Corn Oil: 2.5 mg/mL (5.02 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.0095 mL10.0476 mL20.0953 mL100.4763 mL
5 mM0.4019 mL2.0095 mL4.0191 mL20.0953 mL
10 mM0.2010 mL1.0048 mL2.0095 mL10.0476 mL
20 mM0.1005 mL0.5024 mL1.0048 mL5.0238 mL
50 mM0.0402 mL0.2010 mL0.4019 mL2.0095 mL
100 mM0.0201 mL0.1005 mL0.2010 mL1.0048 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy PCC0208009 | purchase PCC0208009 | PCC0208009 cost | order PCC0208009 | PCC0208009 chemical structure | PCC0208009 formula | PCC0208009 molecular weight